Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
复制标题
DOI:
10.1186/s12951-022-01575-7
复制
发表时间:
2022-08-11
影响因子:
10.2
通讯作者:
Liao, Mei-Yi
中科院分区:
文献类型:
--
作者:
Chin, Yu-Cheng;Yang, Li-Xing;Hsu, Fei-Ting;Hsu, Che-Wei;Chang, Te-Wei;Chen, Hsi-Ying;Chen, Linda Yen-Chien;Chia, Zi Chun;Hung, Chun-Hua;Su, Wu-Chou;Chiu, Yi-Chun;Huang, Chih-Chia;Liao, Mei-Yi
The escape of bladder cancer from immunosurveillance causes monotherapy to exhibit poor efficacy; therefore, designing a multifunctional nanoparticle that boosts programmed cell death and immunoactivation has potential as a treatment strategy. Herein, we developed a facile one-pot coprecipitation reaction to fabricate cluster-structured nanoparticles (CNPs) assembled from Fe3O4 and iron chlorophyll (Chl/Fe) photosensitizers. This nanoassembled CNP, as a multifunctional theranostic agent, could perform red-NIR fluorescence and change the redox balance by the photoinduction of reactive oxygen species (ROS) and attenuate iron-mediated lipid peroxidation by the induction of a Fenton-like reaction. The intravesical instillation of Fe3O4@Chl/Fe CNPs modified with 4-carboxyphenylboronic acid (CPBA) may target the BC wall through glycoproteins in the BC cavity, allowing local killing of cancer cells by photodynamic therapy (PDT)-induced singlet oxygen and causing chemodynamic therapy (CDT)-mediated ferroptosis. An interesting possibility is reprogramming of the tumor microenvironment from immunosuppressive to immunostimulatory after PDT-CDT treatment, which was demonstrated by the reduction of PD-L1 (lower “off” signal to the effector immune cells), IDO-1, TGF-β, and M2-like macrophages and the induction of CD8+ T cells on BC sections. Moreover, the intravesical instillation of Fe3O4@Chl/Fe CNPs may enhance the large-area distribution on the BC wall, improving antitumor efficacy and increasing survival rates from 0 to 91.7%. Our theranostic CNPs not only demonstrated combined PDT-CDT-induced cytotoxicity, ROS production, and ferroptosis to facilitate treatment efficacy but also opened up new horizons for eliminating the immunosuppressive effect by simultaneous PDT-CDT. The online version contains supplementary material available at 10.1186/s12951-022-01575-7.
登录
查看更多内容
影响因子:
12.4
作者:
Blau R;Epshtein Y;Pisarevsky E;Tiram G;Israeli Dangoor S;Yeini E;Krivitsky A;Eldar-Boock A;Ben-Shushan D;Gibori H;Scomparin A;Green O;Ben-Nun Y;Merquiol E;Doron H;Blum G;Erez N;Grossman R;Ram Z;Shabat D;Satchi-Fainaro R
通讯作者:
Satchi-Fainaro R
影响因子:
64.5
作者:
Dixon SJ;Lemberg KM;Lamprecht MR;Skouta R;Zaitsev EM;Gleason CE;Patel DN;Bauer AJ;Cantley AM;Yang WS;Morrison B 3rd;Stockwell BR
通讯作者:
Stockwell BR
影响因子:
12.4
作者:
Hartmans, Elmire;Tjalma, Jolien J. J.;Nagengast, Wouter B.
通讯作者:
Nagengast, Wouter B.
影响因子:
16.6
作者:
Huo M;Wang L;Chen Y;Shi J
通讯作者:
Shi J
影响因子:
14
作者:
Guo, Ranran;Wang, Siqi;Zhang, Peng
通讯作者:
Zhang, Peng